Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05460611 · ClinicalTrials.gov registry record · NA
1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia
A NA study of Androgenetic Alopecia and Scarring Alopecia, sponsored by Montefiore Medical Center.
- Recruiting
- Registry status
- NA
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT05460611 is a NA study of Androgenetic Alopecia and Scarring Alopecia that is actively recruiting participants, run by Montefiore Medical Center. The registered enrollment target is 10 participants, below the 164-participant average among 16 other Androgenetic Alopecia trials with a reported enrollment target (94% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05460611, a NA study of Androgenetic Alopecia and Scarring Alopecia, is actively recruiting participants, sponsored by Montefiore Medical Center.
- RECRUITING
- Registry status
- NA
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
Single-center, open-label, baseline-controlled, pilot study evaluating the use of a Nonablative 1470 nm laser for the treatment of androgenetic alopecia and scarring alopecia.
Conditions Studied
Interventions
- DEVICE Sciton HALO 1470nm Non-ablative laser
Study Locations (1)
New York
- Montefiore Einstein Advanced Care - Elmsford
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2023-12-07 |
| Est. Completion | 2026-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05460611
The ClinicalTrials.gov registry entry for NCT05460611 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 164-participant average among 16 other Androgenetic Alopecia trials with a reported enrollment target (94% lower). The listed sponsor is Montefiore Medical Center, which has 345 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Androgenetic Alopecia appearing as the primary indexed condition, and to 1 intervention - of which Sciton HALO 1470nm Non-ablative laser is the first listed.
NCT05460611 reports 1 study location spanning 1 distinct geographic area - top geographies include New York.
Frequently Asked Questions
What is clinical trial NCT05460611 about?
NCT05460611 is a clinical study titled "1470nm Laser for the Treatment of Androgenetic Alopecia and Scarring Alopecia". Single-center, open-label, baseline-controlled, pilot study evaluating the use of a Nonablative 1470 nm laser for the treatment of androgenetic alopecia and scarring alopecia.
What is the current status of trial NCT05460611?
This trial is currently recruiting. It is a NA study. The enrollment target is 10 participants. The study started on 2023-12-07. Estimated completion is 2026-07.
What conditions does trial NCT05460611 study?
This clinical trial studies the following conditions: Androgenetic Alopecia, Scarring Alopecia.
What interventions are being tested in trial NCT05460611?
The interventions under investigation include: Sciton HALO 1470nm Non-ablative laser (DEVICE).
Who is sponsoring clinical trial NCT05460611?
This trial is sponsored by Montefiore Medical Center, which has 345 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05460611 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Androgenetic Alopecia
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Sham LaserCap vs. LaserCap SD vs. LaserCap HD+
RECRUITING · NA
-
The Effect of Platelet Rich Plasma on Non-scarring Alopecia
COMPLETED · NA
-
Penetration-enhanced Direct DBD Non-thermal Plasma for Hair Loss
COMPLETED · NA
-
Computer-Assisted Versus Manual Hair Harvest Comparative Study
COMPLETED · NA
-
A Study Evaluating the Hair Regrowth Efficacy and Safety of ALRV5XR in Female Subjects With Hair Loss
COMPLETED · NA
-
A Randomized, Double-blind Clinical Trial to Evaluate the Safety and Efficacy of the X5 HairLaser for the Treatment of Androgenetic Alopecia in Males
COMPLETED · NA
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.